Abstract
Dendrimers are polymeric compounds with highly branched structures and functionally tunable peripheral groups. Because of their low polydispersity, high degree of molecular uniformity, and precisely controlled structure, dendrimers are excellent models for demonstrating a variety of biological activities. With the attachment of metals ions and/or metals, metallodendrimers or dendrimer nanocomposites, respectively, provide diverse characters for a variety of applications. Functionalization with additional moieties, such as targeted peptides or chromophores, yields metallodendrimers that can find powerful applications and exceed the capabilities of nondendritic molecules or small molecule analogs. This review introduces the background of metallodendrimers and dendrimer nanocomposites. Biomedical applications of metallodendrimers and dendrimer nanocomposites will be discussed, including biomimetic catalysts, imaging contrast agents (especially for MRI imaging), or biomedical sensors and therapeutic agents.
Keywords: Metallodendrimers, dendrimer nanocomposites, biomimetic catalysts, contrast agents, biosensors, therapeutic agents, thermodynamic effects, epoxidation reaction, folate, magnetic resonance imaging (MRI)
Current Pharmaceutical Design
Title: Metallodendrimers and Dendrimer Nanocomposites
Volume: 17 Issue: 22
Author(s): Yi-Hsuan Tang, Adela Ya-Ting Huang, Po-Yu Chen, Hui-Ting Chen and Chai-Lin Kao
Affiliation:
Keywords: Metallodendrimers, dendrimer nanocomposites, biomimetic catalysts, contrast agents, biosensors, therapeutic agents, thermodynamic effects, epoxidation reaction, folate, magnetic resonance imaging (MRI)
Abstract: Dendrimers are polymeric compounds with highly branched structures and functionally tunable peripheral groups. Because of their low polydispersity, high degree of molecular uniformity, and precisely controlled structure, dendrimers are excellent models for demonstrating a variety of biological activities. With the attachment of metals ions and/or metals, metallodendrimers or dendrimer nanocomposites, respectively, provide diverse characters for a variety of applications. Functionalization with additional moieties, such as targeted peptides or chromophores, yields metallodendrimers that can find powerful applications and exceed the capabilities of nondendritic molecules or small molecule analogs. This review introduces the background of metallodendrimers and dendrimer nanocomposites. Biomedical applications of metallodendrimers and dendrimer nanocomposites will be discussed, including biomimetic catalysts, imaging contrast agents (especially for MRI imaging), or biomedical sensors and therapeutic agents.
Export Options
About this article
Cite this article as:
Tang Yi-Hsuan, Ya-Ting Huang Adela, Chen Po-Yu, Chen Hui-Ting and Kao Chai-Lin, Metallodendrimers and Dendrimer Nanocomposites, Current Pharmaceutical Design 2011; 17 (22) . https://dx.doi.org/10.2174/138161211797052367
DOI https://dx.doi.org/10.2174/138161211797052367 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Role of Streptokinase as a Virulence Determinant of Streptococcus pyogenes – Potential for Therapeutic Targeting
Current Drug Targets Resveratrol, a Phytochemical Inducer of Multiple Cell Death Pathways: Apoptosis, Autophagy and Mitotic Catastrophe
Current Medicinal Chemistry An Up-date of Olive Oil Phenols in Inflammation and Cancer: Molecular Mechanisms and Clinical Implications
Current Medicinal Chemistry Lack of Interaction of the NMDA Receptor Antagonists Dextromethorphan and Dextrorphan with P-Glycoprotein
Current Drug Metabolism Biologically Active Selenophenes and Benzo[b]selenophenes
Current Organic Synthesis Genetic and Non-Genetic Determinants of the Pharmacological Activity of Statins
Current Drug Metabolism Potential Novel Targets in Breast Cancer
Current Pharmaceutical Biotechnology Tumor Invasion and Oxidative Stress: Biomarkers and Therapeutic Strategies
Current Molecular Medicine Poly-L-arginine: Enhancing Cytotoxicity and Cellular Uptake of Doxorubicin and Necrotic Cell Death
Anti-Cancer Agents in Medicinal Chemistry Surface Modification of Nanocarriers for Cancer Therapy
Current Nanoscience Cox Inhibitors as Potential Chemotherapic Drugs for Mesothelioma
Current Respiratory Medicine Reviews microRNAs in Cancer: Lessons from Melanoma
Current Pharmaceutical Design Novel Paramagnetic Contrast Agents for Molecular Imaging and Targeted Drug Delivery
Current Pharmaceutical Biotechnology Novel Gastrin Receptor-Directed Contrast Agents - Potential in Brain Tumor Magnetic Resonance Imaging
Medicinal Chemistry Cancer Prevention with Promising Natural Products: Mechanisms of Action and Molecular Targets
Anti-Cancer Agents in Medicinal Chemistry Pharmacological Aspects of (-)-Deprenyl
Current Medicinal Chemistry MutS Homologues hMSH4 and hMSH5: Genetic Variations, Functions, and Implications in Human Diseases
Current Genomics Molecular Identification of Phytochemical for Anticancer Treatment
Anti-Cancer Agents in Medicinal Chemistry Purification and Characterization of a Lectin from the Indian Cultivar of French Bean Seeds
Protein & Peptide Letters A New Strategy to Target Acute Myeloid Leukemia Stem and Progenitor Cells Using Chidamide, a Histone Deacetylase Inhibitor
Current Cancer Drug Targets